The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,3-Dihydro-2-benzyl-5-(2-nitrobenzyl)-1,5-benzothiazepin-4(5H)-one ID: ALA2334795
PubChem CID: 71578377
Max Phase: Preclinical
Molecular Formula: C23H20N2O3S
Molecular Weight: 404.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]
Standard InChI: InChI=1S/C23H20N2O3S/c26-23-15-19(14-17-8-2-1-3-9-17)29-22-13-7-6-12-21(22)24(23)16-18-10-4-5-11-20(18)25(27)28/h1-13,19H,14-16H2
Standard InChI Key: JWGACCWJXAJASM-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
10.4869 -17.7113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3049 -17.7355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7330 -17.0403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3443 -16.3205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5231 -16.3002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0987 -16.9961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9954 -18.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9943 -18.8431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7023 -19.2521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7006 -17.6147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4084 -18.8423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4092 -18.0200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0552 -17.5021 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0568 -19.3574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8613 -17.6796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8628 -19.1712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2177 -18.4242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3749 -19.8081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0512 -20.1746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3408 -20.5784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6373 -20.1611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9273 -20.5642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9213 -21.3823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6313 -21.7955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3383 -21.3900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2824 -16.9793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0460 -21.8010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7549 -21.3945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0436 -22.6181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 11 2 0
12 10 2 0
10 7 1 0
11 12 1 0
12 13 1 0
11 14 1 0
13 15 1 0
14 16 1 0
15 17 1 0
16 17 1 0
16 18 2 0
14 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
15 26 1 0
26 6 1 0
27 28 2 0
27 29 1 0
25 27 1 0
M CHG 2 27 1 29 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.49Molecular Weight (Monoisotopic): 404.1195AlogP: 5.24#Rotatable Bonds: 5Polar Surface Area: 63.45Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.17CX LogD: 5.17Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.01
References 1. Zhang P, Hu HR, Bian SH, Huang ZH, Chu Y, Ye DY.. (2013) Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β)., 61 [PMID:23047001 ] [10.1016/j.ejmech.2012.09.021 ]